Advanced Pharmaceutical Bulletin

Scope & Guideline

Empowering Knowledge in Pharmaceutical Sciences

Introduction

Explore the comprehensive scope of Advanced Pharmaceutical Bulletin through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Advanced Pharmaceutical Bulletin in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2228-5881
PublisherTABRIZ UNIV MEDICAL SCIENCES & HEALTH SERVICES
Support Open AccessYes
CountryIran
TypeJournal
Convergefrom 2011 to 2024
AbbreviationADV PHARM BULL / Adv. Pharm. Bull.
Frequency2 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressDANESHGHAH ST, TABRIZ, REPUBLIC ISLAMIC 51664-14766, IRAN

Aims and Scopes

The 'Advanced Pharmaceutical Bulletin' primarily focuses on innovative research in pharmaceutical sciences, emphasizing drug delivery systems, nanotechnology, and therapeutic strategies. The journal aims to bridge the gap between laboratory research and clinical application, providing insights into the latest methodologies and therapeutic advancements.
  1. Nanotechnology in Drug Delivery:
    The journal extensively covers the development and application of nanotechnology-based systems for drug delivery, including liposomes, nanoparticles, and nanostructured lipid carriers. This focus aims to improve bioavailability, targeted delivery, and therapeutic efficacy.
  2. Therapeutic Innovations:
    Research articles often explore new therapeutic approaches and drug formulations, including the use of novel compounds, plant-derived substances, and bioengineered materials to enhance treatment outcomes for various diseases.
  3. Immunotherapy and Cancer Research:
    The journal features a significant amount of research on immunotherapy, particularly in cancer treatment, exploring the mechanisms of action, efficacy, and potential challenges associated with these advanced therapeutic modalities.
  4. Regenerative Medicine:
    There is a strong emphasis on regenerative medicine, including the use of stem cells and tissue engineering techniques to facilitate recovery and healing in various clinical contexts.
  5. Pharmacokinetics and Pharmacodynamics:
    Studies often investigate the pharmacokinetic and pharmacodynamic properties of drugs, aiming to understand their behavior in biological systems and optimize therapeutic regimens.
The 'Advanced Pharmaceutical Bulletin' has been evolving with emerging trends in pharmaceutical sciences. This section outlines the themes that have gained traction, indicating the direction of future research and innovation within the journal.
  1. Advanced Nanotechnology Applications:
    There is a marked increase in publications focused on advanced nanotechnology applications in drug delivery, including novel nanoparticles, nanovesicles, and liposomes designed for targeted therapy and enhanced bioavailability.
  2. Personalized Medicine and Gene Therapy:
    Recent articles indicate a growing interest in personalized medicine, particularly in gene therapy approaches, CRISPR technology, and targeted treatments that cater to individual patient profiles, thereby enhancing treatment effectiveness.
  3. Microbiome and Pharmacology:
    Research exploring the relationship between the microbiome and pharmacological responses is trending, highlighting the importance of understanding how individual microbiomes can affect drug metabolism and efficacy.
  4. AI and Machine Learning in Drug Development:
    The journal is increasingly publishing studies on the application of artificial intelligence and machine learning in drug discovery and development processes, indicating a shift towards integrating technology in pharmaceutical research.
  5. Regenerative Therapies Utilizing Stem Cells:
    There is a rise in research focusing on regenerative therapies using stem cells and their derivatives, emphasizing their potential in treating various degenerative diseases and injuries.

Declining or Waning

While the journal continues to thrive in many areas, certain themes have shown a decline in prominence over recent years. This section highlights these waning scopes, reflecting shifts in research interests and emerging priorities.
  1. Traditional Drug Formulations:
    Research focusing on conventional drug formulations without novel delivery systems has decreased. There is a noticeable shift towards innovative approaches that leverage nanotechnology and advanced drug delivery systems.
  2. In Vitro Studies Without Clinical Relevance:
    The journal has seen a decline in purely in vitro studies that do not translate into clinical relevance. The focus has shifted towards research that includes in vivo studies or clinical trials to ensure applicability in real-world settings.
  3. Natural Products Without Novel Applications:
    While natural products remain a topic of interest, studies that do not explore novel applications or delivery methods have become less frequent. The journal is more inclined towards research that integrates natural products into innovative therapeutic strategies.
  4. Pharmacological Studies with Limited Innovation:
    Research articles that primarily focus on pharmacological assessments without introducing new methodologies or therapeutic insights have waned. The emphasis is now on studies that provide significant advancements in the field.

Similar Journals

Drug Delivery and Translational Research

Elevating Research for Patient-Centered Drug Solutions.
Publisher: SPRINGER HEIDELBERGISSN: 2190-393XFrequency: 12 issues/year

Drug Delivery and Translational Research (ISSN: 2190-393X | E-ISSN: 2190-3948), published by Springer Heidelberg, stands at the forefront of the Pharmaceutical Sciences discipline, boasting a prestigious impact factor as evidenced by its Q1 category ranking in 2023. This esteemed journal is dedicated to the vital intersection of drug delivery systems and translational research, aiming to bridge the gap between laboratory findings and clinical applications. It features groundbreaking studies that enhance our understanding of drug pharmacokinetics, formulations, and patient-centered research, making it indispensable for researchers, professionals, and students striving to innovate and excel in the field. While the journal operates under a subscription model, its commitment to disseminating high-quality research is reflected in its Scopus rank, placing it in the top 6% of its category (Rank #11/183, 94th percentile). Since its inception in 2011, it has garnered significant attention, promoting advances in pharmacology, toxicology, and pharmaceutics, and continues to be a platform for vital discourse and discovery.

Journal of Pharmaceutical Investigation

Connecting researchers to shape the future of therapeutics.
Publisher: SPRINGERNATUREISSN: 2093-5552Frequency: 6 issues/year

Journal of Pharmaceutical Investigation, published by SPRINGERNATURE, is a leading academic resource in the field of pharmaceutical sciences, offering critical insights and innovative research findings. With an impact factor that underscores its significance, this journal ranks in the Q1 category for both Pharmacology and Pharmaceutical Science as of 2023, showcasing its high-quality publications and rigorous peer-review processes. Operating from the Netherlands, the journal spans from 2012 to 2024, offering a rich archive of interdisciplinary research contributions that advance knowledge in pharmacology, toxicology, and pharmaceutics. It holds impressive Scopus rankings, placing it among the top-tier journals in its categories, which enhances its appeal to researchers, professionals, and students aiming to publish their work or stay up-to-date with the latest advancements in the pharmaceutical field. Engaging with the Journal of Pharmaceutical Investigation not only enriches your understanding but also connects you with a community dedicated to advancing healthcare and therapeutic innovations.

Journal of Research in Pharmacy

Advancing the Frontiers of Pharmaceutical Science
Publisher: MARMARA UNIVISSN: 2630-6344Frequency: 4 issues/year

Journal of Research in Pharmacy, published by Marmara University, serves as a pivotal platform for the dissemination of innovative research in the field of pharmacology and pharmaceutical sciences. With an ISSN of 2630-6344 and an E-ISSN of the same, this journal is dedicated to publishing high-quality research spanning various aspects of pharmacology, toxicology, and pharmaceutics. The journal, categorized in Q3 for both pharmacology (medical) and miscellaneous pharmacology, toxicology, and pharmaceutics in 2023, showcases the ongoing evolution of these disciplines amid growing scientific inquiry. As of now, it ranks #56/80 in general pharmacology, toxicology and pharmaceutics, spotlighting its relevance within the academic community. Although it operates under a traditional access model, the journal is committed to providing researchers, professionals, and students with a comprehensive understanding of contemporary challenges and innovations in pharmacy research. Established in 2019, it continues to foster academic dialogue and contribute significantly to the advancement of pharmacological sciences until at least 2024. For all interested in cutting-edge pharmaceutical research, this journal presents an invaluable resource from its base in Istanbul, Turkey.

PHARMACIA

Bridging the gap between research and real-world pharmacy applications.
Publisher: PENSOFT PUBLISHERSISSN: 0428-0296Frequency: 4 issues/year

PHARMACIA is a distinguished open-access journal, published by PENSOFT PUBLISHERS, that has been a pivotal platform for advancing the field of pharmaceutical sciences since 2007. This journal, with ISSN 0428-0296 and E-ISSN 2603-557X, is based in Bulgaria and continues to publish high-quality research and reviews relevant to pharmacy, pharmacology, and toxicology. Recognized in the Q3 category for Pharmaceutical Sciences and Pharmacology (medical), as well as Q2 in Pharmacy according to the latest rankings, PHARMACIA is celebrated for its commitment to fostering knowledge dissemination and innovation in drug development, therapeutic approaches, and pharmacological research. With a Scopus rank of #17 in Pharmacy and recognition in various health professions, the journal attracts contributions from researchers, professionals, and students seeking to impact the pharmaceutical landscape. Its convenient open-access format ensures that articles are readily available to a global audience, encouraging collaboration and advancement in the life sciences.

Research in Pharmaceutical Sciences

Exploring the Frontiers of Drug Development
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1735-5362Frequency: 6 issues/year

Research in Pharmaceutical Sciences is a premier, peer-reviewed journal published by Wolters Kluwer Medknow Publications, dedicated to advancing the field of pharmacology, toxicology, and pharmaceutics. With an impact factor that positions it in the second quartile of its category (Q2) and a respectable rank of 23 out of 80 in Scopus, this journal serves as an essential platform for researchers, professionals, and students alike, providing open access since 2015 to a wealth of pioneering studies and comprehensive reviews. Based in Mumbai, India, the journal encompasses a diverse range of topics within the pharmaceutical sciences, offering insights that address both theoretical and practical challenges in drug development and safety. As it converges from 2009 to 2024, Research in Pharmaceutical Sciences continues to be a vital source of knowledge, promoting innovation and fostering collaboration within the global scientific community.

DARU-Journal of Pharmaceutical Sciences

Elevating the discourse in drug discovery and pharmacology.
Publisher: SPRINGER INT PUBL AGISSN: Frequency: 2 issues/year

DARU-Journal of Pharmaceutical Sciences is a leading peer-reviewed journal published by SPRINGER INT PUBL AG that focuses on the dynamic and rapidly evolving fields of pharmaceutical sciences, including drug discovery, pharmacology, and toxicology. With an impressive Q2 ranking in both Drug Discovery and Miscellaneous Medicine categories for 2023, this journal stands out as a vital resource for researchers, professionals, and students alike, offering a platform for significant contributions to the scientific community. Covering a comprehensive scope from 2000 to 2024 and indexed by Scopus, the journal ranks within the top percentile in its field, with a ranking of #66/313 in Pharmacology and #34/157 in Drug Discovery, reaffirming its impact and relevance. The journal promotes open access to foster widespread dissemination of knowledge in pharmaceutical sciences, ultimately aiming to bridge the gap between research and clinical applications. For those looking to stay at the forefront of pharmaceutical innovation, DARU represents an invaluable connection to the latest studies and breakthrough findings.

Asian Journal of Pharmaceutical Sciences

Pioneering research at the forefront of pharmaceutical innovation.
Publisher: SHENYANG PHARMACEUTICAL UNIVISSN: 1818-0876Frequency: 6 issues/year

Asian Journal of Pharmaceutical Sciences is a prestigious open-access journal published by Shenyang Pharmaceutical University, dedicated to advancing research and developments in the field of pharmaceutical sciences. Since its inception in 2009, the journal has successfully converged a wealth of knowledge and innovation, demonstrating an impressive track record with its open access model adopted in 2013, ensuring global dissemination of crucial research findings. With an outstanding impact factor and consistently ranked in the Q1 category for both Pharmaceutical Science and Pharmacology in 2023, it ranks among the top journals in its field, as evidenced by its impressive Scopus rankings—4th out of 183 in Pharmaceutical Science and 10th out of 313 in Pharmacology, showcasing its high relevance and credibility (98th and 96th percentiles respectively). Researchers, professionals, and students can access a diverse array of articles that encompass groundbreaking studies, reviews, and reports, solidifying the journal's position as a vital resource for anyone engaged in pharmaceutical research. With its commitment to quality and accessibility, Asian Journal of Pharmaceutical Sciences plays an essential role in fostering innovation and collaboration within the global scientific community.

AAPS Journal

Shaping the Future of Pharmaceutical Research and Applications.
Publisher: SPRINGERISSN: 1550-7416Frequency: 1 issue/year

AAPS Journal, published by Springer in the United States, is a leading peer-reviewed journal dedicated to the advancement of research in the field of Pharmaceutical Sciences. With an impressive Q1 rank in its category and a position within the 81st percentile of Scopus rankings, it serves as a vital resource for researchers and professionals seeking to disseminate impactful findings and innovative methodologies. The journal publishes high-quality original research, review articles, and technical reports aimed at addressing the multifaceted challenges in pharmacology, toxicology, and pharmaceutics. Operating under an Open Access model, AAPS Journal ensures broad dissemination of knowledge, contributing to the enhanced visibility and accessibility of research outputs. With a publication window spanning from 1999 to 2024, it continues to shape the future of pharmaceutical research and its applications. Researchers, students, and industry professionals will find a valuable repository of cutting-edge knowledge in this esteemed journal.

PHARMACEUTICAL RESEARCH

Driving discoveries that shape the future of medicine.
Publisher: SPRINGER/PLENUM PUBLISHERSISSN: 0724-8741Frequency: 12 issues/year

PHARMACEUTICAL RESEARCH, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal in the ever-evolving field of pharmaceutical sciences. With an ISSN of 0724-8741 and an E-ISSN of 1573-904X, this journal has established itself as a critical hub for disseminating innovative research from 1984 to 2024. The journal holds impressive rankings in prominent categories, including Q2 in Biotechnology and Q2 in Pharmaceutical Science, reflecting its robust impact on the global scientific community. The journal aims to provide researchers, professionals, and students with high-quality articles that contribute significantly to the advancement of drug development and medicinal applications. Although it does not currently offer Open Access options, its rigorous peer-review process ensures that only the highest caliber research is published, making it a valuable resource for those seeking to stay at the forefront of pharmaceutical innovation.

TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH

Empowering researchers to shape the future of pharmaceutical sciences.
Publisher: PHARMACOTHERAPY GROUPISSN: 1596-5996Frequency: 2 issues/year

Tropical Journal of Pharmaceutical Research is an esteemed open-access platform dedicated to advancing the field of pharmaceutical sciences, published by the Pharmacotherapy Group in Nigeria. With an ISSN of 1596-5996 and open access established since 2002, this journal serves as a critical resource for researchers, professionals, and students seeking to disseminate and access high-quality research in both pharmaceutical science and pharmacology. Despite its ranking in the third quartile (Q3) for Pharmaceutical Science and the fourth quartile (Q4) in Pharmacology as of 2023, the journal continues to stand out with its commitment to fostering significant dialogue and innovation in the scientific community. Anchored at the University of Benin, Faculty of Pharmacy, the journal invites contributions that explore novel pharmaceutical research, clinical applications, and drug development, playing a vital role in addressing health challenges that are particularly relevant to tropical regions. Researchers can look forward to publishing their findings in a journal that not only promotes the sharing of knowledge but also enhances the scientific discourse within a rapidly evolving field.